Drug-Coated Balloons Expand Treatment Options
IMPROVE-IT: Ezetimibe plus simvastatin reduces total, recurrent CV events
Lipid Forum II Highlights
Best of Lipid Forum III
The FDA has expanded the approved use of the CoreValve system to include aortic valve-in-valve replacement, according to an agency press release.
The new approval expands the authorized use of the transcatheter aortic valve replacement system (Medtronic) to patients in need of tissue aortic valve replacement who are also at high or extreme risk for complications associated with traditional open-heart surgery, according to the release.
This activity is supported by an educational grant from Amgen, Inc.
This activity is supported by an educational grant from Eisai, Inc. and Vivus, Inc.
Polypill could change secondary prevention strategies for US cardiologists
Treatment of VTE: Warfarin and parenteral anticoagulation still have a role
Appraisal of the National Lipid Association recommendations on cholesterol management
This feature offers timely executive summaries of the most relevant journals in cardiology.
Snapshot summaries of recent study results in cardiology.
Your central portal for information presented at ACC 2015.
Your resource for news and videos from SCAI 2014.
This exclusive Healio resource provides you a comprehensive window into what your colleagues and key opinion leaders are saying about current and future drugs and devices and their impact on patient outcomes.
Related story »
View past polls »
Search Healio's robust listing of national and international medical meetings.
©2015 All Rights Reserved.